F
Forte Biosciences, Inc. (FBRX)
NCM – Real vaqt narxi. Valyuta: USD
21.03
+2.32 (12.40%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
21.03
0.00 (0.00%)
Bozordan keyin: Jun 26, 2026, 4:43 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
21.03
+2.32 (12.40%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
21.03
0.00 (0.00%)
Bozordan keyin: Jun 26, 2026, 4:43 PM EDT
Forte Biosciences, Inc. Qo'shma Shtatlarda klinik bosqichdagi biofarmatsevtika kompaniyasi sifatida faoliyat yuritadi. Kompaniyaning asosiy mahsuloti FB-102 hisoblanadi, bu turli autoimmün kasalliklar va autoimmün bilan bog'liq holatlar, masalan, çölyak kasalligi, vitiligо, alopetsiya areata va 1-toifa diabet uchun mo'ljallangan CD122 ga qarshi o'ziga xos monoklonal antitelar terapiyasidir. Forte Biosciences, Inc. shtab-kvartirasi Dallasda, Texasda joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Barbara K. Finck M.D. | Acting Senior Medical Clinician & Director |
| Dr. Paul A. Wagner Ph.D. | CEO, President & Chairman |
| Mr. Antony A. Riley CPA | Chief Financial Officer |
| Mr. Christopher Roenfeldt | Chief Operating Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-06-08 | S-3/A | d117004ds3a.htm |
| 2026-06-02 | S-8 | d13894ds8.htm |
| 2026-06-02 | S-3 | d117004ds3.htm |
| 2026-06-02 | 8-K | d110060d8k.htm |
| 2026-05-14 | 8-K | d95486d8k.htm |
| 2026-05-11 | 10-Q | fbrx-20260331.htm |
| 2026-04-29 | DEF 14A | d936120ddef14a.htm |
| 2026-04-29 | ARS | d66937dars.pdf |
| 2026-04-09 | 8-K | d128424d8k.htm |
| 2026-04-01 | 8-K | d63145d8k.htm |